CAMP4 to Participate in Chardan’s 10th Annual Healthcare Conference
Key Highlights
- ➤CAMP4 to participate in Chardan’s 10th Annual Healthcare Conference
- ➤Panel on RNA medicines and transcriptome engineering scheduled for October 20, 2026
- ➤Webcast available through CAMP4’s investor relations website
WATERTOWN, Mass., Oct. 14, 2026 (GLOBE NEWSWIRE) -- CAMP4 Therapeutics Corporation (“CAMP4”) (Nasdaq: CAMP), a clinical-stage biopharmaceutical company developing a pipeline of regulatory RNA-targeting therapeutics designed to upregulate gene expression with the goal of restoring healthy protein levels to treat a broad range of genetic diseases, today announced that the company will participate in a panel during Chardan’s 10(th) Annual Healthcare Conference on October 20, 2026. Details below:
The event will be webcast and can be accessed on the investor relations page of CAMP4’s website at www.investors.camp4tx.com. A replay of the webcast will be archived on the CAMP4 website for 30 days following the conference.
Get started
Create a free account to read the full story.